The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin

The 2 histone deacetylase inhibitors (HDACIs) approved for the treatment of cutaneous T-cell lymphoma (CTCL) including mycosis fungoides/sezary syndrome (MF/SS), suberoylanilide hydroxamic acid (SAHA) and romidepsin, are associated with low rates of overall response and high rates of adverse effects...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Moyal, Lilach, Feldbaum, Nataly, Goldfeiz, Neta, Rephaeli, Ada, Nudelman, Abraham, Weitman, Michal, Tarasenko, Nataly, Gorovitz, Batia, Maron, Leah, Yehezkel, Shiran, Amitay-Laish, Iris, Lubin, Ido, Hodak, Emmilia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709199/
https://ncbi.nlm.nih.gov/pubmed/26752418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0146115
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi